【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 14
2 Introduction 15
2.1 Cardiac Rhythm Management Devices Overview 15
3 Products under Development 17
3.1 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 17
3.2 Cardiac Rhythm Management Devices – Pipeline Products by Segment 18
3.3 Cardiac Rhythm Management Devices – Pipeline Products by Territory 20
3.4 Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path 21
3.5 Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date 22
3.6 Cardiac Rhythm Management Devices – Ongoing Clinical Trials 24
4 Cardiac Rhythm Management Devices – Pipeline Products under Development by Companies 25
4.1 Cardiac Rhythm Management Devices Companies – Pipeline Products by Stage of Development 25
4.2 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 27
5 Cardiac Rhythm Management Devices Companies and Product Overview 31
5.1 AI Medical Semiconductor Ltd. Company Overview 31
5.1.1 AI Medical Semiconductor Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 AIS Inc. Company Overview 33
5.2.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.3 Biotronik SE & Co. KG Company Overview 34
5.3.1 Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Boston Scientific Corporation Company Overview 45
5.4.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 45
5.5 Boston TransTec, LLC Company Overview 76
5.5.1 Boston TransTec, LLC Pipeline Products & Ongoing Clinical Trials Overview 76
5.6 CardiaLen, Inc. Company Overview 78
5.6.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.7 CVRx, Inc. Company Overview 80
5.7.1 CVRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.8 DHS Medical Company Overview 84
5.8.1 DHS Medical Pipeline Products & Ongoing Clinical Trials Overview 84
5.9 Duke University Company Overview 86
5.9.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 86
5.10 EBR Systems, Inc. Company Overview 88
5.10.1 EBR Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.11 Endurance Rhythm Inc. Company Overview 92
5.11.1 Endurance Rhythm Inc. Pipeline Products & Ongoing Clinical Trials Overview 92
5.12 Greatbatch, Inc. Company Overview 93
5.12.1 Greatbatch, Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.13 Hadasit Medical Research Services & Development Ltd Company Overview 95
5.13.1 Hadasit Medical Research Services & Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
5.14 Impulse Dynamics N.V. Company Overview 97
5.14.1 Impulse Dynamics N.V. Pipeline Products & Ongoing Clinical Trials Overview 97
5.15 Imricor Medical Systems, Inc. Company Overview 102
5.15.1 Imricor Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.16 InnerPulse, Inc. Company Overview 103
5.16.1 InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.17 Kenergy Inc. Company Overview 105
5.17.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.18 Krisara Engineering, LLC Company Overview 107
5.18.1 Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 107
5.19 LifeWave Hi-Tech Medical Devices Ltd. Company Overview 108
5.19.1 LifeWave Hi-Tech Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview 108
5.20 Mathematical Bio-Solutions Inc. Company Overview 110
5.20.1 Mathematical Bio-Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.21 Mayo Clinic. Company Overview 111
5.21.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 111
5.22 Medtronic plc Company Overview 115
5.22.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 115
5.23 MicroPort Scientific Corporation Company Overview 126
5.23.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 126
5.24 MRI Interventions, Inc Company Overview 130
5.24.1 MRI Interventions, Inc Pipeline Products & Ongoing Clinical Trials Overview 130
5.25 NanoLinea Company Overview 132
5.25.1 NanoLinea Pipeline Products & Ongoing Clinical Trials Overview 132
5.26 NDSU Research Foundation Company Overview 133
5.26.1 NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 133
5.27 NuVascular Technologies Inc Company Overview 134
5.27.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 134
5.28 Odem Medical Ltd. Company Overview 135
5.28.1 Odem Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 135
5.29 Perpetuum Ltd. Company Overview 138
5.29.1 Perpetuum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 138
5.30 Queen Mary University of London Company Overview 139
5.30.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 139
5.31 Rochester Institute of Technology Company Overview 140
5.31.1 Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 140
5.32 Semprus BioSciences Company Overview 141
5.32.1 Semprus BioSciences Pipeline Products & Ongoing Clinical Trials Overview 141
5.33 Smartwave Medical Ltd Company Overview 142
5.33.1 Smartwave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 142
5.34 Sorin Group Italia S.r.l Company Overview 143
5.34.1 Sorin Group Italia S.r.l Pipeline Products & Ongoing Clinical Trials Overview 143
5.35 Sorin S.p.A. (Inactive) Company Overview 148
5.35.1 Sorin S.p.A. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 148
5.36 St. Jude Medical, Inc. Company Overview 174
5.36.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 174
5.37 The Johns Hopkins University Company Overview 189
5.37.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 189
5.38 The University of Utah Company Overview 197
5.38.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 197
5.39 TransWorld Med Corporation Company Overview 198
5.39.1 TransWorld Med Corporation Pipeline Products & Ongoing Clinical Trials Overview 198
5.40 U.S. Stem Cell, Inc. Company Overview 201
5.40.1 U.S. Stem Cell, Inc. Pipeline Products & Ongoing Clinical Trials Overview 201
5.41 University of Bern Company Overview 203
5.41.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview 203
5.42 University of California, Los Angeles Company Overview 204
5.42.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 204
5.43 University of Leicester Company Overview 205
5.43.1 University of Leicester Pipeline Products & Ongoing Clinical Trials Overview 205
5.44 University of Michigan Company Overview 206
5.44.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 206
6 Cardiac Rhythm Management Devices- Recent Developments 208
7 Appendix 390
7.1 Methodology 390
7.2 About GlobalData 392
7.3 Contact Us 393
7.4 Disclaimer 393
【レポート販売概要】
■ タイトル：世界の心調律管理装置開発動向：医療機器パイプライン分析2015■ 英文：Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0130EPD
■ 調査対象地域：グローバル
- 医療レポート：Meningococcal Disease-疫学予測（～2022）EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an incidence of one to three cases per 100,000 population worldwide (Giuliani et al., 2006). Strains of Neisseria meningitidis are classified based on the chemical composition of unique polysaccharide cap …
- ウッドコーティング剤の欧州市場：樹脂種類別（ポリウレタン、ニトロセルロース、アクリル、不飽和ポリエステル、その他）、技術別（水性、従来式固形溶剤、高固形溶剤、粉体塗装、放射線硬化、その他）、用途別（家具、建具、フローリング、その他）The Europe wood coatings market was valued at $2.4 billion in 2018, and is projected to reach $3.9 billion by 2026, growing at a CAGR of 6.0% from 2019 to 2026. Wood coatings are chemical formulations generally used for wood processing. These coatings provide the superior quality on the wood surface and are used for variety of purposes, which include better hygiene, stabilization, and decoration o …
- ガスタービンサービスの世界市場予測：ヘビーデューティ型、航空機転用型The gas turbine services market is projected to grow at a CAGR of 4.1% from 2016 to 2021 to reach a market of USD 18.45 Billion by 2021. The growth is attributed to the up gradation of aging fleet of gas turbines, stringent emission norms for gas turbines and increase in demand of gas turbines owing to the shale gas production boom. The report segments the gas turbine services market based on end- …
- ソフトスキルトレーニングの世界市場2016-2020About Soft Skills TrainingSoft skills can be broadly categorized under three segments: character, interpersonal skills, and critical and creative thinking. Soft skills play a crucial role in enabling individuals to communicate effectively, manage a team with good interpersonal skills, and solve problems. Therefore, apart from training students and employees in technical skills, organizations and e …
- モレキュラーシーブの世界市場2016-2020About Molecular Sieves Molecular sieves contain minuscule holes or pores of consistent size. These pores permit molecules of small dimension to enter the sieve, while larger molecules get separated. Molecular sieves are produced from raw materials such aluminosilicate minerals, silicon dioxide, and mesoporous silica. An example of molecular sieve is crystalline metal aluminosilicate, which has thr …
- Crimson Exploration Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Crimson Exploration Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Crimson Exploration Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 航空サイバーセキュリティの世界市場予測2016-2026The latest report from business intelligence provider visiongain offers comprehensive analysis of the global aviation cyber security market. Visiongain assesses that this market will generate revenues of $1,862m in 2016. Now: Hackers bombard aviation sector with over 1,000 attacks per month. This is an example of the business critical headline that you need to know about - and more importantly, yo …
- 世界のポリカーボネート樹脂市場2015The Global Polycarbonate Resin Industry Report 2015 is a professional and in-depth study on the current state of the Polycarbonate Resin industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Polycarbonate Resin market analysis is provided for the international markets including development trends, compet …
- 義歯の世界市場2019-2023About this market Edentulism or tooth loss is a condition characterized by the partial or complete loss of teeth as a result of injury or diseases such as tooth decay, tooth trauma, or gum disease. Edentulism is common among older people and affects the person's facial appearance and ability to eat and talk. Also, the growing incidence of causative factors on dental health such as smoking, alcohol …
- ターゲットドローン（無人標的機）の世界市場予測（～2022年）“Target Drones offer a solution for threat simulation trainings” The target drones market is projected to grow from USD 3.79 billion in 2016 to USD 6.20 billion by 2022, at a CAGR of 8.55% from 2016 to 2022. The growth of the target drones market can be mainly attributed to factors, such as increased emphasis on enhanced military training and various advantages of target drones over manned target …
- 世界のポリミキシン市場2015Global Polymixin Industry Report 2015 is a professional and in-depth study on the current state of the Polymixin industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Polymixin market analysis is provided for the international markets including development trends, competitive landscape analysis, and key …
- 飼料用プレミックスの世界市場：ビタミン、ミネラル、 アミノ酸、抗生物質In order to cater to the demands for quality meat with increasing meat consumption across the globe, animal breeders are focusing to boost animal health and their nutritious diet. Feed premixes are consequently seen as those products that can improve the return on investments. Premixes perform the essential role of improving feed nutritional value and performance of animals, while preventing them …
- ファイバレーザの世界市場2015-2019About fiber lasers Fiber lasers are used for material processing applications such as cutting and welding in the automotive, manufacturing, heavy industry, and consumer electronic sectors. They are also being used extensively for medical applications. Apart from the welding and cutting processes, fiber lasers are used for marking and engraving components for better traceability and for removing pr …
- 脂質異常症治療薬の世界市場予測および分析PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2023 Summary GlobalData estimates that the total market size for the 8MM in 2013 was $15.4bn, comprised of $11.0bn in branded drug sales (72%) and $4.4bn in generic sales (28%). GlobalData expects that the dyslipidemia drug market will grow at a CAGR of 9.4% over the ten year forecast period, resulting in a market value of $37 …
- 女性用健康リハビリ製品の世界市場分析：製品別（整形外科ケア、尿失禁、乳がんケア、妊娠出産後ケア）、治療別（理学療法、作業療法）、セグメント予測、2014-2025The global women’s health rehabilitation products market is expected to reach USD 4.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth over the forecast period, owing to increasing prevalence of chronic diseases coupled with rising female geriatric population. Growing global population coupled with increasing birth rates is …
